Charles Schwab’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.25M Buy
156,122
+11,499
+8% +$166K ﹤0.01% 2628
2025
Q1
$998K Buy
144,623
+2
+0% +$14 ﹤0.01% 2846
2024
Q4
$767K Buy
144,621
+4,452
+3% +$23.6K ﹤0.01% 2999
2024
Q3
$512K Hold
140,169
﹤0.01% 3153
2024
Q2
$383K Buy
140,169
+115,502
+468% +$315K ﹤0.01% 3296
2024
Q1
$85.8K Hold
24,667
﹤0.01% 3319
2023
Q4
$35.3K Hold
24,667
﹤0.01% 3435
2023
Q3
$36K Hold
24,667
﹤0.01% 3438
2023
Q2
$38.7K Hold
24,667
﹤0.01% 3456
2023
Q1
$37.7K Hold
24,667
﹤0.01% 3395
2022
Q4
$41.4K Hold
24,667
﹤0.01% 3395
2022
Q3
$31K Hold
24,667
﹤0.01% 3428
2022
Q2
$42K Sell
24,667
-102,969
-81% -$175K ﹤0.01% 3419
2022
Q1
$314K Hold
127,636
﹤0.01% 3206
2021
Q4
$478K Buy
127,636
+4,824
+4% +$18.1K ﹤0.01% 3160
2021
Q3
$771K Buy
122,812
+5,362
+5% +$33.7K ﹤0.01% 2975
2021
Q2
$1.16M Buy
117,450
+10,986
+10% +$108K ﹤0.01% 2873
2021
Q1
$995K Buy
106,464
+5,391
+5% +$50.4K ﹤0.01% 2862
2020
Q4
$486K Buy
101,073
+4,905
+5% +$23.6K ﹤0.01% 3003
2020
Q3
$386K Sell
96,168
-4,438
-4% -$17.8K ﹤0.01% 2956
2020
Q2
$462K Buy
100,606
+2,673
+3% +$12.3K ﹤0.01% 2865
2020
Q1
$320K Sell
97,933
-4,508
-4% -$14.7K ﹤0.01% 2868
2019
Q4
$442K Buy
102,441
+5,177
+5% +$22.3K ﹤0.01% 2865
2019
Q3
$383K Buy
97,264
+5,894
+6% +$23.2K ﹤0.01% 2902
2019
Q2
$425K Buy
91,370
+6,880
+8% +$32K ﹤0.01% 2884
2019
Q1
$355K Buy
84,490
+12,690
+18% +$53.3K ﹤0.01% 2888
2018
Q4
$247K Hold
71,800
﹤0.01% 2987
2018
Q3
$309K Hold
71,800
﹤0.01% 2997
2018
Q2
$267K Buy
+71,800
New +$267K ﹤0.01% 3009
2017
Q2
Sell
-44,800
Closed -$121K 3144
2017
Q1
$121K Hold
44,800
﹤0.01% 2994
2016
Q4
$149K Hold
44,800
﹤0.01% 3007
2016
Q3
$134K Hold
44,800
﹤0.01% 2987
2016
Q2
$186K Buy
+44,800
New +$186K ﹤0.01% 2963